Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Physiologically Based Pharmacokinetic Modeling for Sequential Metabolism: Effect of CYP2C19 Genetic Polymorphism on Clopidogrel and Clopidogrel Active Metabolite Pharmacokinetics

Nassim Djebli, David Fabre, Xavier Boulenc, Gérard Fabre, Eric Sultan and Fabrice Hurbin
Drug Metabolism and Disposition April 2015, 43 (4) 510-522; DOI: https://doi.org/10.1124/dmd.114.062596
Nassim Djebli
Sanofi R&D, Drug Disposition, Disposition Safety and Animal Research, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Fabre
Sanofi R&D, Drug Disposition, Disposition Safety and Animal Research, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xavier Boulenc
Sanofi R&D, Drug Disposition, Disposition Safety and Animal Research, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gérard Fabre
Sanofi R&D, Drug Disposition, Disposition Safety and Animal Research, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Sultan
Sanofi R&D, Drug Disposition, Disposition Safety and Animal Research, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabrice Hurbin
Sanofi R&D, Drug Disposition, Disposition Safety and Animal Research, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 43 no. 4 510-522
DOI 
https://doi.org/10.1124/dmd.114.062596
PubMed 
25609219

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received December 9, 2014
  • Accepted January 21, 2015
  • Published online February 20, 2015.

Article Versions

  • Earlier version (January 21, 2015 - 06:56).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Nassim Djebli,
  2. David Fabre,
  3. Xavier Boulenc,
  4. Gérard Fabre,
  5. Eric Sultan, and
  6. Fabrice Hurbin
  1. Sanofi R&D, Drug Disposition, Disposition Safety and Animal Research, Montpellier, France
  1. Address correspondence to:
    Dr. Nassim Djebli, Drug Disposition, Disposition Safety and Animal Research, Sanofi Recherche et Développement, 371 rue du Professeur Blayac, Montpellier, France. E-mail: nassim.djebli{at}sanofi.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 201763222
Sep 201713619
Oct 201744025
Nov 2017513232
Dec 2017347017
Jan 2018139417
Feb 20181024534
Mar 2018820545
Apr 201878626
May 2018711821
Jun 2018911233
Jul 2018812719
Aug 2018311524
Sep 201855521
Oct 2018211543
Nov 2018812331
Dec 2018712338
Jan 201999737
Feb 2019149344
Mar 201976247
Apr 201984472
May 2019712550
Jun 2019424750
Jul 2019543346
Aug 20191339657
Oct 2019718469
Nov 2019811272
Dec 201939118
Jan 202058943
Feb 202048750
Mar 2020611371
May 20202224280
Jun 20201116548
Jul 2020414631
Aug 2020416048
Sep 2020382063
Oct 202027132366
Nov 202019142469
Dec 20209111846
Jan 20211073486
Feb 202113744947
Mar 202190278
Apr 20217041313
May 20218181011
Jun 202187534
Jul 20217151011
Aug 20216251212
Sep 20215201212
Oct 202147784
Nov 2021368106
Dec 202118088
Jan 20222111013
Feb 20222241416
Mar 20221551414
Apr 20221331512
May 202216145
Jun 202211131
Jul 20221471118
Aug 202292912
Sep 202218152
Oct 20229895
Nov 20224284
Dec 20226356
Jan 202310085
Feb 202365124
Mar 202318954

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 43 (4)
Drug Metabolism and Disposition
Vol. 43, Issue 4
1 Apr 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Physiologically Based Pharmacokinetic Modeling for Sequential Metabolism: Effect of CYP2C19 Genetic Polymorphism on Clopidogrel and Clopidogrel Active Metabolite Pharmacokinetics
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

PBPK Modeling for Clopidogrel and Its Active Metabolite

Nassim Djebli, David Fabre, Xavier Boulenc, Gérard Fabre, Eric Sultan and Fabrice Hurbin
Drug Metabolism and Disposition April 1, 2015, 43 (4) 510-522; DOI: https://doi.org/10.1124/dmd.114.062596

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

PBPK Modeling for Clopidogrel and Its Active Metabolite

Nassim Djebli, David Fabre, Xavier Boulenc, Gérard Fabre, Eric Sultan and Fabrice Hurbin
Drug Metabolism and Disposition April 1, 2015, 43 (4) 510-522; DOI: https://doi.org/10.1124/dmd.114.062596
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A PBPK model for CBD in adults and children
  • Olanzapine Glucuronidation in Humanized Mice
  • rs2242480 Regulates the Expression of CYP3A4 and CYP3A5
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics